Cascadian Therapeutics, Inc. - EFFECT filing on 2018-03-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 21, 2018

Accession Number:

0001193125-18-076396

Submission Type:

POS AM